Breaking News Instant updates and real-time market news.

FIS

FIS

$105.83

-0.555 (-0.52%)

, GPN

Global Payments

$104.34

0.02 (0.02%)

11:25
12/13/18
12/13
11:25
12/13/18
11:25

Cantor Fitzgerald financial tech analyst to hold a luncheon meeting

Financial Technology Services Analyst Foresi holds a Tech Tidbits luncheon meeting with Bob Chakravorti, CEO of Chakra Advisors focused on real-time Payments, "The New Rails", in New York on December 13 at 12 pm.

FIS

FIS

$105.83

-0.555 (-0.52%)

GPN

Global Payments

$104.34

0.02 (0.02%)

IMXI

International Money Express

$11.99

(0.00%)

JKHY

Jack Henry

$134.03

-0.73 (-0.54%)

MA

MasterCard

$197.93

-2.47 (-1.23%)

PYPL

PayPal

$87.94

1.44 (1.66%)

SQ

Square

$62.89

-0.78 (-1.23%)

V

Visa

$137.17

-0.67 (-0.49%)

WP

Worldpay

$81.97

1.27 (1.57%)

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 29

    Jan

FIS FIS
$105.83

-0.555 (-0.52%)

11/14/18
LEHM
11/14/18
INITIATION
LEHM
Overweight
Barclays initiates coverage of U.S. payment processors with PayPal as top pick
As noted earlier, Barclays analyst Ramsey El-Assal initiated a group of 20 U.S. companies in the Payments, Processing, and related IT Services sector with Overweight-rated PayPal (PYPL) as his Top Pick. The analyst cites the company's "100% exposure to high-growth digital channels" along with its "clean balance sheet substantial cash position" that bring it a "strategic opportunity. El-Assal is also particularly positive on Overweight-rated WorldPay (WP) based on its strong growth potential from its exposure to "tech-enabled channels" and merger synergies, FirstData (FDC) based on the accelerating growth of its merchant channels, and Square (SQ)," whose Subscription & Services segment is blurring the lines between Payments and software". The analyst contends that the extent of being "tech-enabled" is a key differentiator in the Payments industry, assigning an Overweight rating to Alliance Data Systems (ADS), ADP (ADP), Cardtronics (CATM), Fidelity National (FIS), First Data (FDC), Fiserv (FISV), Fleetcor Technologies (FLT), Global Payments (GPN), Green Dot (GDOT), Mastercard (MA), Total System Services (TSS), Visa (V), and WEX Inc (WEX). El-Assal assigns Equal-weight ratings to EVO Payments (EVOP) and Paychex (PAYX), stating that while the companies are "solid performers" in the space, their valuation is seen as more balanced. The analyst rates MoneyGram (MGI) and Western Union (WU) at Underweight, saying that the former will struggle to re-ignite positive growth as the costs associated with regulatory scrutiny weigh on its profits and the latter will be challenged by "periodic pricing pressure eroding margins over a long period of time."
12/05/18
SPHN
12/05/18
NO CHANGE
Target $118
SPHN
Overweight
Stephens says FIS remains undervalued after headquarter visit
After a visit to the company's headquarters, Stephens analyst Brett Huff continues to view FIS as undervalued. The analyst expects the stock to "grind higher" as revenue growth accelerates in 2019 along with good margin expansion. He keeps an Overweight rating on the stock with a $118 price target.
12/11/18
GSCO
12/11/18
UPGRADE
Target $128
GSCO
Buy
FIS upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst James Schneider upgraded FIS to Buy and raised his price target for the shares to $128 from $108. The analyst restacked his ratings in the Payments & IT Services sector to reflect a more defensive posture.
12/11/18
GSCO
12/11/18
UPGRADE
Target $128
GSCO
Buy
FIS upgraded to Buy at Goldman Sachs on improved revenue and margin profile
As reported earlier, Goldman Sachs analyst James Schneider upgraded FIS to Buy and raised his price target for the shares to $128 from $108 as part of his broader sector research note titled Payments & IT Services 2019 Outlook. The analyst sees the company benefiting from its defensive position given that the large portion of its revenues are "tied to mission-critical bank operations." Schneider also believes that investors are "under-appreciating" the gross margin and revenue "quality" improvements made by the management of FIS as it divests the company's non-core businesses to streamline its mix.
GPN Global Payments
$104.34

0.02 (0.02%)

10/31/18
KEYB
10/31/18
NO CHANGE
Target $135
KEYB
Overweight
Global Payments price target raised to $135 from $130 at KeyBanc
KeyBanc analyst Josh Beck raised his price target for Global Payments to $135 from $130 after the company reported a "solid" Q3 despite some incremental FX headwinds. Market sentiment seems to be increasingly focused on 2019 potential, and given Global's contribution from tech-led channels could rise to 45% next year with a medium-term goal of 60%, the analyst is increasingly confident in the strategy. He reiterates an Overweight rating on the shares.
11/05/18
GUGG
11/05/18
DOWNGRADE
GUGG
Neutral
Global Payments downgraded to Neutral from Buy at Guggenheim
11/14/18
LEHM
11/14/18
INITIATION
Target $136
LEHM
Overweight
Global Payments initiated with an Overweight at Barclays
Barclays analyst Ramsey El-Assal initiated Global Payments with an Overweight and $136 price target.
IMXI International Money Express
$11.99

(0.00%)

12/06/18
PIPR
12/06/18
INITIATION
Target $17
PIPR
Overweight
International Money Express initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Jason Deleeuw started International Money Express with an Overweight rating and $17 price target. The company is a "fast-growing" money transfer remittance provider with ~5,000 agent send locations in the U.S. and ~50,000 agent receive locations in Latin America, Deleeuw tells investors in a research note. He believes International Money is taking "significant" market share in the U.S.-Latin America corridor.
10/11/18
CANT
10/11/18
INITIATION
Target $15
CANT
Overweight
International Money Express initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi initiated International Money Express with an Overweight and $15 price target.
09/12/18
09/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Arch Therapeutics (ARTH) initiated with a Buy at Ladenburg. 2. International Money Express (IMXI) initiated with a Buy at BTIG. 3. Intercept (ICPT) initiated with a Buy at Roth Capital. 4. Huntington Ingalls (HII) initiated with a Buy at Buckingham. 5. Zogenix (ZGNX) initiated with an Outperform at Northland. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/18
BTIG
09/12/18
INITIATION
Target $16
BTIG
Buy
International Money Express initiated with a Buy at BTIG
BTIG analyst Mark Palmer initiated International Money Express with a Buy rating and a price target of $16, saying the company is well positioned to sustain its rapid revenue growth rates given its "differentiated agent strategy" in money transfer and its focus on U.S.-Mexico and U.S.-Guatemala corridors. The analyst also cites the company's operating focus on agent productivity rather than agent count, helping it expand market share and grow margins through its "superior" network efficiency. Palmer adds that the valuation of International Money Express at 12-times expected FY19 EBITDA is attractive given that the company is in the early stages of growth in both new and existing send and receive markets.
JKHY Jack Henry
$134.03

-0.73 (-0.54%)

01/23/18
DADA
01/23/18
INITIATION
Target $118
DADA
Neutral
Jack Henry initiated with a Neutral at DA Davidson
As reported earlier, DA Davidson analyst Peter Heckmann initiated Jack Henry with a Neutral rating and a price target of $118. Heckmann says the company can grow its EPS over the medium term, but believes that the forward multiple is now at the high end of its long-term historical range.
01/23/18
01/23/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Abeona Therapeutics (ABEO) assumed with an Outperform at RBC Capital. 2. Jack Henry (JKHY) initiated with a Neutral at DA Davidson. 3. Woodward (WWD) re-initiated with a Market Perform at Barrington. 4. Navistar (NAV) initiated with a Neutral at Buckingham. 5. Global Blood Therapeutics (GBT) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/07/18
CANT
06/07/18
NO CHANGE
Target $141
CANT
Overweight
Jack Henry price target raised to $141 from $132 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi raised his price target for Jack Henry & Associates to $141 after marketing with management. The analyst sees "evolving catalysts" to drive sales growth, including Banno payments and a better spending environment. Jack Henry has a mid-single-digit growth rate with long-term margin expansion potential, Foresi tells investors in a research note. He keeps an Overweight rating on the shares.
08/23/18
CANT
08/23/18
NO CHANGE
Target $169
CANT
Overweight
Jack Henry price target raised to $169 from $141 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi yesterday afternoon raised his price target for Jack Henry & Associates to $169 following the company's Q4 results. Jack Henry's market share gains in small U.S. banks and credit unions serve as a "nice foundation" for growth initiatives, including the move from "In"- to "Out"-sourcing, ePayments, and cross-selling opportunities, Foresi tells investors in a research note. He keeps a Buy rating on the shares.
MA MasterCard
$197.93

-2.47 (-1.23%)

10/31/18
LOOP
10/31/18
NO CHANGE
Target $232
LOOP
Buy
MasterCard 'looks interesting' after market retracement, says Loop Capital
Loop Capital analyst Joseph Vafi kept his Buy rating and $232 price target on MasterCard after its Q3 earnings beat, saying shares look "more interesting" in the wake of the recent market retracement. The analyst points to the company's 17% constant-currency revenue growth and ongoing leverage gains in the quarter, along with the and global economy "through the lens of Mastercard payment volume. Vafi added that the "ongoing migration away from cash and to electronic currencies" add to the company's tailwinds.
11/14/18
LEHM
11/14/18
INITIATION
Target $240
LEHM
Overweight
MasterCard initiated with an Overweight at Barclays
Barclays analyst Ramsey El-Assal initiated MasterCard with an Overweight and $240 price target.
12/05/18
WEDB
12/05/18
NO CHANGE
Target $220
WEDB
Outperform
MasterCard capital return shows confidence in 'resilient model,' says Wedbush
After MasterCard announced a 33% dividend increase and authorized a new $6.5B share buyback program, Wedbush analyst Moshe Katri said the capital return plans show the company's confidence in its "resilient business model." The analyst, who continues to view MasterCard as a defensive name with various "protection buffers" for both revenue growth and earnings, maintains an Outperform rating and $220 price target on the shares.
PYPL PayPal
$87.94

1.44 (1.66%)

11/15/18
11/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. PayPal (PYPL) initiated with an Overweight at Barclays. 2. Albemarle (ALB) initiated with a Neutral at Buckingham. 3. Galapagos NV (GLPG) initiated with a Strong Buy at Raymond James. 4. Mogo Finance (MOGO) initiated with a Buy at B. Riley FBR. 5. Altice USA (ATUS) initiated with a Buy at UBS. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/27/18
NOMU
11/27/18
NO CHANGE
Target $103
NOMU
Buy
Fears of fraud at PayPal's Venmo are overblown, says Nomura Instinet
Nomura Instinet analyst Bill Carcache believes fears of fraud loss at PayPal's Venmo over overblown following Sunday's Wall Street Journal article. The analyst keeps a Buy rating on the shares with a $103 price target. In response to increasing fraud, Venmo temporarily suspended instant transfers, which were quickly reintroduced after updates, and generated $1B of volume in September, Carcache tells investors in a research note.
11/27/18
SPHN
11/27/18
NO CHANGE
Target $108
SPHN
Overweight
PayPal fraud issue at Venmo looks to be under control, says Stephens
After The Wall Street Journal reported over the holiday weekend that internal documents indicated PayPal experienced greater than expected fraud losses associated with its Venmo instant transfer feature, Stephens analyst Brett Huff noted that his take is that the fraud issue looks to be under control given that the article indicates fraud rates have been coming down. Even if it were assumed that the continued high levels of fraud outlined in the article of 0.35% continued, he thinks the negative financial impact that would occur would be fairly muted, Huff said. Separately, it was reported that the U.K.'s Competition Authority has concerns about PayPal's iZettle deal. However, Huff said he believes the company could have remediation ideas to help ease competitive worries. He reiterates an Overweight rating and $108 price target on PayPal shares.
12/10/18
UBSW
12/10/18
NO CHANGE
Target $95
UBSW
Buy
Investors 'bullish' on PayPal, says UBS
UBS analyst Eric Wasserstrom said the firm conducted the "Market Thinking Game" to determine institutional investors' views about PayPal, telling investors in a research note that the results showed there is a positive view of PayPal, with 81% of investors bullish or very bullish, with their stance deriving from expectations of strong volume growth, and to a lesser extent from Venmo monetization. Wasserstrom has a Buy rating and $95 price target on PayPal.
SQ Square
$62.89

-0.78 (-1.23%)

11/29/18
SPHN
11/29/18
NO CHANGE
SPHN
Square price target lowered to $75 from $85 at Stephens
Stephens analyst Brett Huff maintained an Equal-Weight rating on Square, and lowered his price target on shares to $75 from $85. Huff believes Square still has great long-term opportunities, and "remains compelled by the company's revenue growth, margin expansion, new products, use of artificial intelligence, expansion into consumer/CashApp/banking, and low-capital intensity geographic expansion," but believes this is reflected in Square's current valuation.
11/20/18
NOMU
11/20/18
NO CHANGE
Target $107
NOMU
Buy
Square price target lowered to $107 from $125 at Nomura Instinet
Nomura Instinet analyst Dan Dolev lowered his price target for Square to $107 after hosting investor meetings with Stacey Finerman and Nikhil Dixit from the company's Investor Relations team. The analyst keeps a Buy rating on the shares. He dropped his fiscal 2019 EBITDA estimate for Square to $464M from $508M.
11/14/18
LEHM
11/14/18
INITIATION
Target $96
LEHM
Overweight
Square initiated with an Overweight at Barclays
Barclays analyst Ramsey El-Assal initiated Square with an Overweight and $96 price target.
V Visa
$137.17

-0.67 (-0.49%)

10/25/18
MSCO
10/25/18
NO CHANGE
Target $165
MSCO
Overweight
Visa trends remain healthy despite some forex headwinds, says Morgan Stanley
Morgan Stanley analyst James Faucette said Visa's Q4 results and FY19 outlook point to a continuation of solid underlying trends globally, despite some headwinds resulting from the stronger U.S. dollar. Despite the expected forex headwind, Faucette points to Europe, India and Visa Direct as among the company's multiple potential upside drivers. He maintains an Overweight rating and $165 price target on Visa shares.
10/25/18
BMOC
10/25/18
NO CHANGE
Target $196
BMOC
Outperform
Visa price target raised to $196 from $187 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Visa to $196 after its Q4 earnings beat, saying the stock "remains" his "highest conviction" Outperform recommendation. The analyst notes that the lower than expected incentives and taxes "more than offset" lower revenues, which were driven by declines in China volumes and higher expenses. Fotheringham also raises his FY19 EPS view by 5c to $5.40 to reflect higher-than-previously-modeled net revenues coming from faster volume growth.
11/14/18
LEHM
11/14/18
INITIATION
Target $170
LEHM
Overweight
Visa initiated with an Overweight at Barclays
Barclays analyst Ramsey El-Assal initiated Visa an Overweight and $170 price target.
WP Worldpay
$81.97

1.27 (1.57%)

11/08/18
SPHN
11/08/18
NO CHANGE
Target $111
SPHN
Overweight
Worldpay Q4 guidance appears conservative, says Stephens
Stephens analyst Brett Huff said Worldpay's Q4 guidance appears conservative, noting that it implies a growth deceleration of 100bps despite the company indicating no deterioration in trends, as well as an expected acceleration in the tech segment. In terms of 2019, the company said on its Q3 call that it sees no reason revenue won't grow by a high-single digits percentage, Huff added. He has an Overweight rating and $111 price target on Worldpay shares, but said his estimates and target are under review on the heels of the earnings report and call.
11/14/18
LEHM
11/14/18
INITIATION
Target $108
LEHM
Overweight
Worldpay initiated with an Overweight at Barclays
Barclays analyst Ramsey El-Assal initiated Worldpay with an Overweight and $108 price target.
11/19/18
BARD
11/19/18
NO CHANGE
Target $109
BARD
Outperform
Worldpay elevated to Fresh Pick at Baird
Baird analyst David Koning elevated Worldpay to Fresh Pick citing its recent pullback as he views the stock as compelling and a big winner in a secular growth industry. The analyst noted expectations have been a little strong, but he believes the company is taking market share and leverage is falling. Koning reiterated his Outperform rating and $109 price target on Worldpay shares.

TODAY'S FREE FLY STORIES

BA

Boeing

$371.03

3.73 (1.02%)

, UAL

United Airlines

$92.97

0.43 (0.46%)

12:41
11/15/19
11/15
12:41
11/15/19
12:41
Hot Stocks
United Airlines pulls 737 Max jets off schedule until March 4 »

United Airlines (UAL) is…

BA

Boeing

$371.03

3.73 (1.02%)

UAL

United Airlines

$92.97

0.43 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$4.50

-0.38 (-7.79%)

12:38
11/15/19
11/15
12:38
11/15/19
12:38
Hot Stocks
Empery Asset Management reports 7.17% passive stake in Applied DNA Sciences »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
11/15/19
11/15
12:35
11/15/19
12:35
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

TSLA

Tesla

$349.70

0.19 (0.05%)

, VWAGY

Volkswagen

$0.00

(0.00%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Periodicals
VW CEO says company has no plans to cooperate with Tesla, Reuters reports »

Volkswagen (VWAGY) CEO…

TSLA

Tesla

$349.70

0.19 (0.05%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$5.17

0.03 (0.58%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

, AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

12:23
11/15/19
11/15
12:23
11/15/19
12:23
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been higher…

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

MSFT

Microsoft

$149.59

1.53 (1.03%)

UAA

Under Armour

$17.82

0.69 (4.03%)

UA

Under Armour

$16.04

0.48 (3.08%)

AMRN

Amarin

$22.89

1.4 (6.51%)

RH

RH

$188.04

12.85 (7.33%)

BRK.A

Berkshire Hathaway

$329,640.00

545 (0.17%)

BRK.B

Berkshire Hathaway

$219.62

0.26 (0.12%)

FTCH

Farfetch

$9.69

2.2 (29.37%)

AMAT

Applied Materials

$62.33

5.44 (9.56%)

ACB

Aurora Cannabis

$3.00

-0.29 (-8.81%)

OXY

Occidental Petroleum

$38.90

1.14 (3.02%)

TORC

resTORbio

$1.16

-6.77 (-85.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 28

    Dec

  • 06

    Jan

TORC

resTORbio

$1.14

-6.79 (-85.62%)

12:21
11/15/19
11/15
12:21
11/15/19
12:21
Downgrade
resTORbio rating change  »

resTORbio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

12:18
11/15/19
11/15
12:18
11/15/19
12:18
Periodicals
We Company facing SEC probe into possible rule breaches, Bloomberg says »

We Company's WeWork…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCBP

First Choice Bank

$22.49

-0.01 (-0.04%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
First Choice Bancorp announces resignation of CFO Lynn Hopkins »

First Choice Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$120.92

-0.03 (-0.02%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
AmEx reports October consumer card write-off rate 2.3% vs. 2.0% last month »

American Express reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/15/19
11/15
12:16
11/15/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$219.62

1.07 (0.49%)

12:10
11/15/19
11/15
12:10
11/15/19
12:10
Hot Stocks
Amgen treatment of multiple myeloma granted FDA orphan designation »

Amgen's treatment of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AXGT

Axovant

$4.71

-0.05 (-1.05%)

12:07
11/15/19
11/15
12:07
11/15/19
12:07
Hot Stocks
Axovant granted FDA orphan designation for treatment of GM1 gangliosidosis »

Axovant Sciences was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$43.75

1.85 (4.42%)

, FB

Facebook

$194.64

1.49 (0.77%)

12:05
11/15/19
11/15
12:05
11/15/19
12:05
Recommendations
Lyft, Facebook, Amazon.com, Netflix, Twitter, IAC analyst commentary  »

JPMorgan adds Lyft to…

LYFT

Lyft

$43.75

1.85 (4.42%)

FB

Facebook

$194.64

1.49 (0.77%)

AMZN

Amazon.com

$1,747.79

-6.92 (-0.39%)

NFLX

Netflix

$293.25

3.57 (1.23%)

TWTR

Twitter

$29.38

0.49 (1.70%)

IAC

IAC

$223.02

2.85 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 09

    Dec

  • 10

    Dec

  • 06

    Feb

AUPH

Aurinia Pharmaceuticals

$5.37

0.23 (4.47%)

12:05
11/15/19
11/15
12:05
11/15/19
12:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:05
11/15/19
11/15
12:05
11/15/19
12:05
General news
Fed Q4 Nowcasts revised lower. »

Fed Q4 Nowcasts revised…

ENVA

Enova International

$22.15

-1.895 (-7.88%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Enova International falls -8.0% »

Enova International is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANG

Cango

$6.24

-0.6 (-8.77%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Cango falls -8.4% »

Cango is down -8.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRA

Contura Energy

$8.50

-0.88 (-9.38%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Contura Energy falls -9.5% »

Contura Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCB

Itau Corpbanca

$8.63

1.12 (14.91%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Itau Corpbanca rises 17.7% »

Itau Corpbanca is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$14.89

2.76 (22.75%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Intelsat rises 22.5% »

Intelsat is up 22.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

FTCH

Farfetch

$9.68

2.19 (29.24%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Farfetch rises 29.4% »

Farfetch is up 29.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLD

TopBuild

$107.78

-1.78 (-1.62%)

, FBHS

Fortune Brands

$63.13

-0.01 (-0.02%)

11:57
11/15/19
11/15
11:57
11/15/19
11:57
Downgrade
TopBuild, Fortune Brands rating change  »

TopBuild downgraded to…

BLD

TopBuild

$107.78

-1.78 (-1.62%)

FBHS

Fortune Brands

$63.13

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANGI

Angi Homeservices

$7.55

-0.03 (-0.40%)

11:55
11/15/19
11/15
11:55
11/15/19
11:55
Options
Angies List put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.